Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance
2021 · Nature Communications · 269 citations
https://doi.org/10.1038/s41467-021-23793-7
Y
Yasuaki Anami
Brown Foundation(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
1.6K
Citations
17
h-index
23
i10-index
Yasuaki Anami is an academic researcher from Brown Foundation. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research. The author has an h-index of 17, co-authored 73 publications.
ORCID: 0000-0001-5136-7708Papers by this author
worksEnzymatic conjugation using branched linkers for constructing homogeneous antibody–drug conjugates with high potency
2017 · Organic & Biomolecular Chemistry · 89 citations
https://doi.org/10.1039/c7ob01027c
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors
2022 · Cell Reports · 46 citations
https://doi.org/10.1016/j.celrep.2022.110839
Antibody–Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer
2024 · Cancer Research · 13 citations
https://doi.org/10.1158/0008-5472.can-24-0798
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat